FutureSearch Clinical Trials, LP

Austin, Texas 78756

0 studies enrolling now · 26 studies all time

What they study most

ADHD, Adult Attention Deficit Hyperactivity Disorder, Anxiety, Separation, Asthma, Attention Deficit Hyperactivity Disorder, Binge Eating Disorder, Bipolar Depression, Central Nervous System Diseases, Cognition, Generalized Anxiety Disorder (GAD), Major Depressive Disorder, Phobia, Social

Studies at this site

• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) — Completed
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) — Completed
• The Efficacy and Safety of PRC-063 in Adult ADHD Patients — Completed
• A Twelve Week, Open Label Extension Study in Patients With Schizophrenia — Completed
• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
• Dasotraline Adult ADHD Study — Completed
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features — Stopped early
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders — Completed
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression — Completed
• PEARL Schizophrenia Maintenance — Completed
• PRC-063 in Adolescent ADHD — Completed
• Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD — Completed
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder — Completed
• A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction — Completed
• Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD) — Completed
• Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia — Completed
• Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD) — Completed
• Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) — Completed
• Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD) — Completed
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents — Completed